The surgical robot maker is considering operational changes to counter tariff impacts on sales and demand but foresees no substantial benefits this year, Jamie Samath, chief finan ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $630 from $670 and keeps an Outperform rating on the shares as part ...

While Intuitive is still reporting steady growth in the placement of its da Vinci surgical robots—as well as the number of procedures they have performed—the company said it expects to take a ...

Surgical is warning that President Donald Trump's import taxes and retaliation from trade partners could have a significant ...

Intuitive (Nasdaq: ISRG) announced two studies supporting the use of robotic-assisted surgery and its benefits to patients.

October 17, 2024 Intuitive beats quarterly profit estimates on strong demand for surgical robots Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

Intuitive Surgical Inc ISRG reported better-than-expected first-quarter financial results Tuesday after the bell. Intuitive Surgical reported first-quarter revenue of $2.25 billion, beating ...

Medical devices, or the medtech sector, are not immune from the reciprocal tariffs announced by Trump yesterday.

(Reuters) - Medical device maker Intuitive Surgical said on Tuesday that U.S. tariffs will increasingly weigh on its business for the rest of the year, disrupting operations in China and ...